CHRISTINE CONNER: Open Payments
NPI 1295120533 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 42 payments from 11 companies in 2025. Trend: 2023 $404 · 2024 $370 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $214 |
| GENZYME CORPORATION | 10 | $207 |
| GlaxoSmithKline, LLC. | 12 | $173 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Grifols USA, LLC | 1 | $36 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Insmed, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $25 |
Products named: DUPIXENT, NUCALA, FASENRA, AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, Prolastin-C Liquid, INSPIRE.
Industry payments across MO — which companies pay providers there.
